BGLC · Forms 3, 4, 5
Insider trades at BioNexus Gene Lab Corp
No open-market insider buys or sells at BioNexus Gene Lab Corp in the last 90 days; 11 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for BioNexus Gene Lab Corp (BGLC) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Insider trades in the last 90 days
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Lee Su-Leng Tan | Chief Executive Officer | Award | 338,709 | Form 4 | |||
| Chee Keong Yap | Director | Award | 32,258 | Form 4 | |||
| Bin Abdul Hamid Muhammad Azrul | Director | Award | 32,258 | Form 4 | |||
| Set Fui Chong | Chief Financial Officer | Award | 96,774 | Form 4 | |||
| Jook Yuen Low | Director | Award | 16,129 | Form 4 | |||
| FIDELION DIAGNOSTICS PTE. LTD. | Became an insider (Form 3) | Form 3 | |||||
| Lee Su-Leng Tan | CEO | Became an insider (Form 3) | Form 3 | ||||
| Bin Abdul Hamid Muhammad Azrul | Director | Became an insider (Form 3) | Form 3 | ||||
| Chee Keong Yap | Director | Became an insider (Form 3) | Form 3 | ||||
| Jook Yuen Low | Director | Became an insider (Form 3) | Form 3 | ||||
| Set Fui Chong | CFO | Became an insider (Form 3) | Form 3 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.